Mapping community pharmacy services in Brazil: a scoping review

Abstract The delivery of clinical pharmacy services has been growing in Brazilian community pharmacies, and it is necessary to have a comprehensive understanding of the topic. This scoping review aimed to provide an overview of Brazilian studies about clinical pharmacy services in community pharmaci...

Full description

Saved in:
Bibliographic Details
Published inBrazilian Journal of Pharmaceutical Sciences Vol. 58
Main Authors Garabeli, Aline Ansbach, Benetoli, Arcelio, Halila, Gerusa Clazer, Machinski, Isadora, Tonin, Fernanda Stumpf, Fernandez-Llimos, Fernando, Pontarolo, Roberto
Format Journal Article
LanguageEnglish
Portuguese
Published Universidade de São Paulo, Faculdade de Ciências Farmacêuticas 01.01.2022
Universidade de São Paulo
Subjects
Community pharmacy services
Pharmacists
PHARMACOLOGY & PHARMACY
Pharmacy research
Public Reporting of Healthcare Data
Terminology
Public Reporting of Healthcare Data
Terminology
Pharmacy research
Pharmacists
Community pharmacy services
Online AccessGet full text

Cover

More Information
Summary:Abstract The delivery of clinical pharmacy services has been growing in Brazilian community pharmacies, and it is necessary to have a comprehensive understanding of the topic. This scoping review aimed to provide an overview of Brazilian studies about clinical pharmacy services in community pharmacies. Original research articles, with no restriction of time, study design, or patient’s health condition, were included. Searches were conducted in PubMed, Scopus, Web of Science, Scielo, and Lilacs. Two reviewers conducted the screening, full-text reading, and data extraction independently. ROB and ROBINS-I were used for the assessment of quality. Charts and tables were built to summarise the data. Seventy-two articles were included. A diversity of study designs, number of participants, terms used, and outcomes was found. São Paulo and Sergipe States had the highest number of studies (n=10). Pharmacists’ interventions were not fully reported in 65% of studies, and most studies presented an unclear risk of bias. Studies were very diverse, impairing the comparisons between the results and hindering their reproducibility. This review suggests using guidelines and checklists for better structuration of pharmacists’ interventions as well as reporting results and measuring fidelity in future research.
ISSN:2175-9790
2175-9790
DOI:10.1590/s2175-97902022e20851